EIKN
Eikon Therapeutics, Inc.Company with tickers: EIKN
CIK
1861123
CUSIP
282564103
Shares Outstanding
54,138,628
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $71,383,000 | USD | 2025-03-31 | 10-Q | 2026-05-11 |
| Research & Development | $56,587,000 | USD | 2025-03-31 | 10-Q | 2026-05-11 |
| Operating Income | $-71,383,000 | USD | 2025-03-31 | 10-Q | 2026-05-11 |
| Net Income | $-68,243,000 | USD | 2025-03-31 | 10-Q | 2026-05-11 |
| EPS (Basic) | $-26.91 | USD/shares | 2025-03-31 | 10-Q | 2026-05-11 |
| EPS (Diluted) | $-26.91 | USD/shares | 2025-03-31 | 10-Q | 2026-05-11 |